People experimenting with tiny doses of GLP-1 drugs such as Wegovy and Zepbound report slimmer waistlines and steadier control over cravings. Interest in microdosing has surged, fueled by cost, side‑effect management, and curiosity about whether lower doses still trigger weight loss. Doctors and researchers caution that science is still catching …